Safety and Efficacy of Telbivudine on Liver Cirrhosis in Patients With Chronic Hepatitis B (CHB)
Status:
Unknown status
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
Antiviral treatment on Chronic Hepatitis B (CHB) patients with liver cirrhosis is compulsory
and effective. Telbivudine, which is superior to lamivudine in the treatment of CHB,is
considered to be appropriate for the antiviral treatment on CHB patients with liver
cirrhosis.